Variables | 30th day functional outcome among survivors n = 91 | Adjusted OR (95% CI) | P-value | |
---|---|---|---|---|
mRS 0–2 (n = 27,29.7%) | mRS 3–5 (n = 64,70.3%) | |||
Age | ||||
< 65 years | 22 (81.5) | 34 (60.7) | 1 | |
≥ 65 years | 5 (14.3) | 30 (85.7) | 5.53 (1.36–22.43) | 0.017 |
Gender | ||||
Male | 17 (29.3) | 41(70.7) | 0.99 (0.34–2.88) | 0.98 |
Female | 10 (30.3) | 23 (69.7) | 1 | |
History of diabetes mellitus | ||||
Yes | 1 (12.5) | 7 (87.5) | 0.29 (0.02–3.97) | 0.35 |
No | 26 (31.3) | 57 (68.7) | 1 | |
Admission Blood glucose level | ||||
≥ 140 mg/dl | 9 (20.9) | 34 (79.1) | 3.83 (1.99–6.19) | 0.041 |
< 140 mg/dl | 18 (37.5) | 30 (62.5) | 1 | |
Type of stroke | ||||
Ischemic | 18 (36.0) | 32 (64.0) | 3.52 (0.96–12.94) | 0.058 |
Hemorrhagic | 9 (21.9) | 32 (78.1) | 1 | |
Admission NIHSS score | ||||
NIHSS > 14 | 3 (9.7) | 28 (90.3) | 0.12 (0.03–0.54) | 0.006 |
NIHSS ≤ 14 | 24 (40.0) | 36 (60.0) |